Challenges Evaluating Chemotherapy-Induced Peripheral Neuropathy in Childhood Cancer Survivors
- PMID: 27251891
- DOI: 10.1177/1043454216651016
Challenges Evaluating Chemotherapy-Induced Peripheral Neuropathy in Childhood Cancer Survivors
Abstract
Children treated for cancer are exposed to a variety of chemotherapeutic agents with known toxicity to the peripheral nervous system. The side effect of peripheral neuropathy can cause changes in sensation, function, and even cause pain. Although peripheral neuropathy is recognized by pediatric oncology nurses as an important and significant side effect, measuring neuropathy can be quite complex for clinical care and research efforts. With more children surviving a cancer diagnosis today, this issue is increasingly important for childhood cancer survivors. This article has reviewed existing literature examining peripheral neuropathy in childhood cancer survivors with particular interest paid to measurement tools available and needs for future research. It is important for nurses to choose appropriate measures for clinical care and research methods in order to have an impact on patients experiencing this condition.
Keywords: childhood cancer survivors; late effects; peripheral neuropathy; peripheral neuropathy measurement.
Similar articles
-
Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.JAMA Neurol. 2018 Aug 1;75(8):980-988. doi: 10.1001/jamaneurol.2018.0963. JAMA Neurol. 2018. PMID: 29799906 Free PMC article.
-
A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).Support Care Cancer. 2017 Jan;25(1):195-204. doi: 10.1007/s00520-016-3404-y. Epub 2016 Sep 9. Support Care Cancer. 2017. PMID: 27612466 Clinical Trial.
-
Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia.Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26471. Epub 2017 Jan 31. Pediatr Blood Cancer. 2017. PMID: 28139029
-
Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity?Am Soc Clin Oncol Educ Book. 2015:e553-60. doi: 10.14694/EdBook_AM.2015.35.e553. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993222 Review.
-
Assessment Tools for Peripheral Neuropathy in Pediatric Oncology: A Systematic Review From the Children's Oncology Group.J Pediatr Oncol Nurs. 2018 Jul/Aug;35(4):267-275. doi: 10.1177/1043454218762705. Epub 2018 Mar 22. J Pediatr Oncol Nurs. 2018. PMID: 29566596 Free PMC article.
Cited by
-
Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review.Lancet Haematol. 2020 May;7(5):e408-e417. doi: 10.1016/S2352-3026(20)30064-8. Lancet Haematol. 2020. PMID: 32359452 Free PMC article.
-
Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions.Front Pain Res (Lausanne). 2022 Mar 14;3:864910. doi: 10.3389/fpain.2022.864910. eCollection 2022. Front Pain Res (Lausanne). 2022. PMID: 35360655 Free PMC article. Review.
-
Assessment of Pediatric Chemotherapy-Induced Peripheral Neuropathy Using a New Patient-Reported Outcome Measure: The P-CIN.J Pediatr Oncol Nurs. 2021 Mar-Apr;38(2):131-141. doi: 10.1177/1043454220980253. Epub 2020 Dec 17. J Pediatr Oncol Nurs. 2021. PMID: 33331218 Free PMC article.
-
The Minnesota Haptic Function Test.Front Psychol. 2019 Apr 17;10:818. doi: 10.3389/fpsyg.2019.00818. eCollection 2019. Front Psychol. 2019. PMID: 31057457 Free PMC article. Review.
-
Newly identified chemotherapy-induced peripheral neuropathy in a childhood cancer survivorship clinic.Pediatr Blood Cancer. 2022 Mar;69(3):e29550. doi: 10.1002/pbc.29550. Epub 2021 Dec 31. Pediatr Blood Cancer. 2022. PMID: 34971076 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
